Font Size: a A A
Keyword [esophagogastric junction]
Result: 41 - 60 | Page: 3 of 8
41. Evaluation Of MMP-9 And MMP-2 And Their Inhibitors TIMP-1 And TIMP-2 In Esophagogastric Junction Adenocarcinoma
42. Clinical Study Of The Gastroesophageal Junction Adenocarcinoma
43. Association Of PD-1 SNPs With Esophagogastric Junction Adenocarcinoma Risk And The Functional Study
44. To Evaluate The Influence Of Different Surgical Resection And Length Of Proximal Margin On The Prognosis Of Patients With Adenocarcinoma Of Esophagogastric Junction
45. Analysis Of Clinical Pathological Features And Prognostic Factors Between 734 Cases Of Hui And Han Patients With Adenocarcinoma Of The Esophagogastric Junction In Ningxia Hui Autonomous Region
46. Differential Over Expression Of ERK Regulated By HER2 And RKIP In Adenocarcinoma Of The Esophagogastric Junction And Distal Stomach
47. Efficacy And Safety Analysis Of Preoperative Concurrent Chemoradiotherapy For Patients With Locally Advanced Adenocarcinoma Of Esophagogastric Junction In Siewert's Type ? And ?
48. Selecting Sensitive Chemotherapeutic Drugs Based On The Genetic Testing In The Application Of The Esophagogastric Junction Carcinoma Treatment
49. Expression Of Promoter Methylation Of MGMT In Adenocarcinoma Of The Esophagogastric Junction
50. Helicobacter Pylori, EBV And The Risk Of Adenocarcinomas Of The Gastric Cardiac And Distal Stomach In North China
51. Application Of Ber-Ep4 Antibody Detection Joint With CD44v6 In The Lower Mediastinal Lymph Nodes Micrometastasis Of The Patients With Siewert Type ? Adenocarcinoma Of The Esophagogastric Junction
52. Characteristics And Clinical Significance Of Lymph Node Metastasis In Adenocarcinoma Of The Esophagogastric Junction And The Reserch Of Molecular Mechanism
53. Comparison Of Postoperative Survival Distribution,prognostic Factors In 217 Patients With Esophagogastric Junction Cancer
54. To Investigate The Value Of Transabdominal Ultrasoud In The Preoperative Assessment Of Adenocarcinoma Of Esophagogastric Junction
55. The Effect Of Minimally Invasive Surgery And Open Surgery On Serum IL-6 And CRP Concentration In Patients With Siewert Type ? Esophageal Gastric Junction Adenocarcinoma
56. Diagnosis And Treatment Of Esophageal Junctional Cancer And Its Controversy
57. Effects Of Preoperative Enteral Nutrition On Postoperative Recent Nutritional Status In Patients With Siewert ? And ? Adenocarcinoma Of Esophagogastric Junction After Neoadjuvant Chemoradiotherapy
58. Relationship Of Dosimetric Parameters Of Irradiated Bone Marrow And Hematologic Toxicities In Locally Advanced Adenocarcinoma Of The Esophagogastric Junction Patients Treated With Preoperative Chemoradiotherapy
59. The Discussion On Clinical Target Volume Delineation Of Adenocarcinoma Of The Esophagogastric Junction
60. The Study Of SOX As An Adjuvant Chemotherapy In Adenocarcinoma Of Esophagogastric Junction
  <<First  <Prev  Next>  Last>>  Jump to